IMR Press / FBL / Volume 10 / Issue 1 / DOI: 10.2741/1543

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Immune peptide enhancement of peptide based vaccines
Show Less
1 Northeastern Ohio Universities College of Medicine, 4209 SR 44, Rootstown, OH 44272, USA
Front. Biosci. (Landmark Ed) 2005, 10(1), 478–482; https://doi.org/10.2741/1543
Published: 1 January 2005
Abstract

Vaccines optimize the presentation of an immunogen to the immune system, oftentimes enhancing or replacing the natural activators of antigen presenting cells in order to promote the delivery and the response of T and B lymphocytes to the immunogen. The purpose of this series is to describe new technologies which allow vaccine design, based on our understanding of the immune response, using different approaches to immune peptide enhancement of peptide based vaccines. In this introduction to the series entitled, "Immune Peptide Enhancement of Peptide Based Vaccines", some of the immunological concepts relevant to vaccine design are presented.

Keywords
Peptide Vaccines
Epitope Enhancement
Immunomodulation
Review
Share
Back to top